These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 2173088)

  • 21. A complex-trapping-blocking (CTB) ELISA, using monoclonal antibodies and detecting specifically antibodies directed against foot-and-mouth disease types A, O and C. II. Application.
    van Maanen C
    Vet Microbiol; 1990 Aug; 24(2):179-91. PubMed ID: 2173249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of vaccination on foot and mouth disease virus transmission among dairy cows.
    Orsel K; de Jong MC; Bouma A; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(2):327-35. PubMed ID: 16949184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response in bovine pharyngeal fluid following foot-and-mouth disease vaccination and, or, exposure to live virus.
    Francis MJ; Ouldridge EJ; Black L
    Res Vet Sci; 1983 Sep; 35(2):206-10. PubMed ID: 6314460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual foot-and-mouth disease virus antibodies in French cattle and sheep six years after the vaccination ban.
    Remond M; Kaiser C; Lebreton FO; Moutou F; Crucière C
    Vet Res; 2001; 32(1):81-6. PubMed ID: 11254180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. I. Screening tests and herd immunity].
    Müller HK; Villinger F; Griot C; Ackermann M; Bruckner L; Kihm U
    Schweiz Arch Tierheilkd; 1989; 131(7):379-86. PubMed ID: 2552579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
    Brehm KE; Kumar N; Thulke HH; Haas B
    Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of effectiveness of FMD vaccine type Asia 1 in neutralization tests in cattle].
    Dimitriadis IA
    Berl Munch Tierarztl Wochenschr; 1993 Apr; 106(4):124-7. PubMed ID: 8387775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous vaccination of cattle with foot-and-mouth disease and vesicular stomatitis live virus vaccines.
    Castañeda J; Espinoza M; Bernal C; Jiménez J; Aguirre L
    Dev Biol Stand; 1976; 35():429-36. PubMed ID: 198310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
    Ackermann M; Müller HK; Bruckner L; Kihm U
    Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.
    van Lierop MJ; van Maanen K; Meloen RH; Rutten VP; de Jong MA; Hensen EJ
    Immunology; 1992 Mar; 75(3):406-13. PubMed ID: 1349300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle.
    Lee F; Jong MH; Yang DW
    Vet Microbiol; 2006 Jun; 115(1-3):14-20. PubMed ID: 16446061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of anti-foot-and-mouth disease vaccine in oil adjuvant in young cattle].
    Brun A; Chappuis G; Favre H; Roulet C; Terré J
    Dev Biol Stand; 1976; 35():117-22. PubMed ID: 198277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.
    Maradei E; La Torre J; Robiolo B; Esteves J; Seki C; Pedemonte A; Iglesias M; D'Aloia R; Mattion N
    Vaccine; 2008 Dec; 26(51):6577-86. PubMed ID: 18835312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the immune response of foot-and-mouth disease vaccine type Asia-1 in pregnant ewes, lambs and evaluation of type O vaccine by challenge.
    Nair SP; Sen AK
    Acta Virol; 1994 Oct; 38(5):257-61. PubMed ID: 7725999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease.
    Parida S; Cox SJ; Reid SM; Hamblin P; Barnett PV; Inoue T; Anderson J; Paton DJ
    Vaccine; 2005 Oct; 23(44):5186-95. PubMed ID: 16039761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experiments on an early protection against foot-and-mouth disease virus.
    Liebermann HT; Thalmann G; Bartels T; Nöckler A
    Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.